A Review of Advancements and Evidence Gaps in Diabetic Retinopathy Screening Models
Elizabeth Pearce,1 Sobha Sivaprasad1,2 1Department of Ocular Biology, Institute of Ophthalmology, University College London, London, UK; 2Medical Retina Department, NIHR Moorfields Biomedical Research Centre, Moorfields Eye Hospital, London, UKCorrespondence: Sobha SivaprasadNIHR Moorfields Biomedic...
Guardado en:
Autores principales: | Pearce E, Sivaprasad S |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/4ff958152c15437faafaecdd9f7fbd8c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Risk factors for neovascular glaucoma after vitrectomy in eyes with proliferative diabetic retinopathy
por: Sakamoto M, et al.
Publicado: (2018) -
Natural History of Diabetic Retinopathy Through Retrospective Analysis in Type 2 Diabetic Patients—An Exploratory Study
por: Mehak Gupta, et al.
Publicado: (2021) -
Subthreshold microsecond laser for proliferative diabetic retinopathy: a randomized pilot study
por: Jhingan M, et al.
Publicado: (2018) -
Visual evoked potentials after panretinal photocoagulation in patients with proliferative diabetic retinopathy
por: Amini Vishte R, et al.
Publicado: (2019) -
Timing of neovascular regression in eyes with high-risk proliferative diabetic retinopathy without macular edema treated initially with intravitreous bevacizumab
por: Shakarchi FI, et al.
Publicado: (2018)